Evelyn joined Daicel Arbor Biosciences as a product development scientist in 2015 to apply her expertise in protein design and engineering for industrial and academic applications to the development of the myTXTL line of cell-free protein expression kits. In her current position as Division Manager for Synthetic Biology, she leads myTXTL product development and R&D operations, coordinates manufacturing of standard and customized kits, and markets the myTXTL product line. Prior to this role, Eggenstein completed her Ph.D. in Prof. Arne Skerra`s laboratory at the Technical University Munich, Germany, where she focused on the construction of Anticalin fusion proteins for therapy and diagnostics. After moving to the Detroit area, Eggenstein pursued her passion for protein science and joined Daicel Arbor Biosciences to develop and market the all-E. coli cell-free myTXTL platform. This has allowed Daicel Arbor Biosciences to become a provider of comprehensive solutions in the synthetic biology market starting from DNA synthesis to protein expression. Evelyn received a B.S. and M.S. in molecular biotechnology from Technical University Munich, and holds a patent on a collection of muteins of a1m lipocalin and method of production thereof.